Delivery Order 36F79719D0160-36C24526N0193
Award Date 12/17/25
Potential Completion Date 12/19/25
Potential Value $19K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Catalyst Pharmaceuticals, Inc., doing business as Catalyst Pharmaceuticals, is for the delivery of the pharmaceutical product AMIFAMPRIDINE (FIRDAPSE) 10MG. The contract, valued at $18,526.09, was awarded by the Department of Veterans Affairs (VA) and its Veterans Health Administration (VHA) network. It is a firm fixed-price delivery order placed against Catalyst's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract has no set-aside...
- This federal contract award was issued by the Veterans Integrated Service Network 20 (VISN 20), a component of the U.S. Department of Veterans Affairs (VA), to Catalyst Pharmaceuticals, Inc. The $132,865.82 firm fixed-price delivery order was placed against Catalyst's Federal Supply Schedule (FSS-61-IB) contract for the pharmaceutical product Amifampridine (Firdapse) 10mg Tablets, which is an FDA-approved treatment for Lambert-Eaton Myasthenic Syndrome (LEMS), a rare autoimmune disorder. The...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Catalyst Pharmaceuticals, Inc., a for-profit pharmaceutical company specializing in rare disease therapies. The contract is for the supply of FIRDAPSE 10 MG, an FDA-approved treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder. The contract has a ceiling value of $18,978.13 and an ultimate completion date of September 29, 2025. The contract is not set-aside and is placed against...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded a $30,608.30 firm fixed price delivery order contract to Catalyst Pharmaceuticals, Inc. for the medication FIRDAPSE. The contract has no set-aside designation and is to be completed by March 13, 2019, with Catalyst Pharmaceuticals performing as the prime contractor. As the award is for a specific medication, it can be inferred this supports the VA's mission to provide healthcare...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,131.67 delivery order to Catalyst Pharmaceuticals, Inc. for FIRDAPSE 10MG. The order was placed against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with a firm fixed price and performance location in Miami, Florida. No set-aside designation was used for this order to supply the drug FIRDAPSE to the agency, which provides healthcare services to...
- Catalyst Pharmaceuticals, Inc. was awarded a $90,692.40 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7. The firm fixed price order is for the emergency procurement of amifampridine to be delivered to the place of performance in Decatur, Georgia by September 30, 2019. No set-aside designation was used for this award placed against GSA Schedule FSS-61-IB to...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Anovorx Distribution LLC, a small business for-profit limited liability company, to provide the medication Firdapse (Amifampridine). The contract has a potential value of $151,359.02 and a completion date of September 19, 2019. Anovorx Distribution LLC has provided various specialty pharmaceutical products to the VA and Department of the Army Medical Command...
- The Department of Veterans Affairs (VA) Veterans Health Administration and Veterans Integrated Service Network 12 awarded a firm fixed price delivery order contract to Acorda Therapeutics, Inc., a biotechnology company that develops drugs to improve therapies for neurological conditions. The $485,835.00 contract is for the delivery of DALFAMPRIDINE 10MG SA, a pharmaceutical product, with a completion date of July 14, 2017. The contract was issued off of the VA's Pharmaceuticals and Drugs Federal...
- The Department of Veterans Affairs (VA) Veterans Health Administration and Veterans Integrated Service Network 12 awarded a firm fixed price delivery order to Acorda Therapeutics, Inc. for the drug Dalfampridine. The $485,835.00 contract is being fulfilled through the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which Acorda holds. Acorda is a biotechnology company that develops drugs to improve therapies for neurological conditions including multiple sclerosis...
- The Department of Veterans Affairs (VA) Veterans Health Administration and Veterans Integrated Service Network 12 awarded a firm fixed price delivery order contract to Acorda Therapeutics, Inc., a biotechnology company that develops drugs to improve therapies for conditions such as multiple sclerosis, spinal cord injury, and Parkinson's disease. The contract, valued at $485,835.00, is for the delivery of DALFAMPRIDINE, a medication used to improve mobility in multiple sclerosis patients. This...